PATENT CLAIM ANALYSIS

Application Number: 16021973
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "220000"]

Abstract:
Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.

Claim (Index 9):
The method of  claim 2 , wherein the first pharmaceutically active compound is medazolam, the second pharmaceutically active compound is ketamine and the third pharmaceutically active compound is metoprolol, wherein the medazolam:ketamine:metoprolol ratio is between about 1:2:1 and about 1:10:1 by mass.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15995875', '15903529', '15903615', '14281288', '12860846']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7987898242289284
- 35 USC 102 Novelty (BERT): 0.5397436617633099
- Combined Prediction Score: 0.7728852079823666
- Mean Citation Score: 284.183712
- Max Citation Score: 375.12076
- Similarity Product: 339.1709388874865

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test